Abstract
A number of widely repeated and factually incorrect myths have pervaded the AIDS research literature, misdirecting research and treatment. Five of the most outstanding are: 1) that all risk groups develop AIDS at the same rate following HIV infection; 2) that there are no true seroreversions following HIV infection; 3) that antibody is protective against HIV infection; 4) that the only way to treat AIDS effectively is through retroviral therapies; and 5) that since HIV is so highly correlated with AIDS incidence, it must be the sole necessary and sufficient cause of AIDS. A huge body of research, reviewed in this paper, demonstrates the falsity of these myths. 1) The average number of years between HIV infection and AIDS is greater than 20 years for mild hemophiliacs, 14 years for young severe hemophiliacs, 10 years for old severe hemophiliacs, 10 years for homosexual men, 6 years for transfusion patients of all ages, 2 years for transplant patients, and 6 months for perinatally infected infants. These differences can only be explained in terms of risk-group associated cofactors. 2) Seroreversions are common. Between 10 and 20 percent of HIV-seronegative people in high risk groups have T-cell immunity to HIV, and may have had one or more verified positive HIV antibody tests in the past. 3) Antibody, far from being protective against HIV, appears to be highly diagnostic of loss of immune regulation of HIV, and some evidence of antibody-enhancement of infection exists. 4) Non-retroviral treatments of HIV infection, including safer sex practices, elimination of drug use, high nutrient diets, and limited reexposure to HIV and its cofactors have proven to be effective means of preventing or delaying onset of AIDS. 5) Many immunosuppressive factors, including drug use, multiple concurrent infections, and exposure to alloantigens, are as highly correlated with AIDS risk groups as HIV. These data are more consistent with AIDS being a multifactorial or synergistic disease than a monofactorial one.
Chapter PDF
Similar content being viewed by others
References
Adams, L.E., R. Donovan-Brand, A. Friedman-Kien, K. Ramahi & E.V. Hess, 1988. Sperm and seminal plasma antibodies in acquired immune deficiency (AIDS) and other associated syndromes. Clin. Immuno. Immunopathol. 46: 442–449.
Anderson, R., 1993. AIDS: trends, predictions, controversy. Nature 363: 393–394.
Andes, W.A., S.R. Rangan & K.M. Wulff, 1989. Exposure of heterosexuals to human immunodeficiency virus and viremia: evidence for continuing risks in spouses of hemophiliacs. Sex Transm. Dis. 16: 68–73.
Anonymous, 1994. Fighting HIV: A clue from hemophilia. Science 263: 27.
Ads, A., J.L. Pomar & E. Saura, 1993. Cardiopulmonary bypass in HIV-positive patients. Ann. Thorac. Surg. 55: 1104–1107.
Aronson, D.L., 1988. Cause of death in hemophilia patients in the United States from 1968–1979. Am. J. Haematol. 27: 7–12.
Atkinson, K., A.J. Dodds, A.J. Concannon & J.C. Biggs, 1987. The development of the acquired immunodeficiency syndrome after bone marrow transplantation. Med. J. Aust. 147: 510–512.
Barnes, D.M., 1988. Obstacles to an AIDS vaccine. Science 240: 719–721.
Biggar, R.J., H.K. Anderson, P. Ebbesen, M. Mebye & J.J. Goedert, 1983. Seminal fluid excretion of cytomegalovirus related to immunosuppression in homosexual men. Br. Med. J. 286: 2010–2012.
Bjork, R.L. Jr., 1991. HIV-1: seven facets of functional molecular mimicry. Immunology Lett. 28: 91–95.
Blanch, S., M. Tardieu, A. Duliege, C. Rouzioux, E le Deist, et al., 1990. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. Am. J. Dis. Child. 144: 1210–1215.
Brown, P., 1992. AIDS researchers focus on immune response. New Scientist 8 August, 16.
Buimovici-Klein, E., M. Lange, K.R. Ong, M.H. Grieco & L.Z. Cooper, 1988. Virus isolation and immune studies in a cohort of homosexual men. J. Med. Virol. 25: 371–385.
Burke, D.S., 1992. Human HIV vaccine trials: Does antibody-dependent enchancement pose a genuine risk? Perspectives Biol. Med. 35: 511–531.
Burger, H. & B. Weiser, 1986. Transient antibody to human immunodeficiency virus. Ann. Intern. Med. 105: 464–465.
Burger, H., B. Weiser, W.S. Robinson, J. Lifson, E. Engleman, et al., 1985. Transient antibody to lymphadenopathy-associated virus/human T-lymphotopic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the aquired immonodeficiency syndrome. Ann. Int. Med. 103: 545–547.
Callen, M., 1990. Surviving AIDS. New York: Harper Collins.
Centers for Disease Control, 1993. HIV/AIDS Surveillance Report, June 1993.
Clerici, M., J.V. Giorg i, C.C. Chou, V.K. Gudeman, J.A. Zack, P. Gupta, H.N. Ho, P.G. Nishanian, J.A. Berzofsky & G.M. Shearer, 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165: 1012–1019.
Clerici, M. & G.M. Shearer, 1993. A TH1 -+ TH2 switch is a critical step in the etiology of HIV infection. Immunology Today 14: 107–111.
Cohen, J., 1993. AIDS research: the mood is uncertain. Science 260: 1254–1255.
Cooper, M.H., D. Maraninchi, J.A. Gastaut, P. Mannoni & Y. Carcassonne, 1993. HIV infection in autologous and allogeneic bone marrow transplant patients: a retrospective analysis of the Marseille bone marrow transplant population. J. Acquir. Immune. Defici. Syndr. 6: 277–284.
Cuthbert, R.J.G., C.A. Ludlum, J. Tucker, et al.,1990. Five year prospective study of HIV infection in the Edinburgh haemophiliac cohort. Br. Med. J. 301: 956–961.
Dalgleish, A.G., S. Wilson, M. Gompels, C. Ludlam, B. Gazzard, A.M. Coates & J. Habeshaw, 1992. T-cell receptor variable gene products and early HIV-1 infection. Lancet 339: 824–828.
Daniel, V., R. Weimer, K. Schimpf & G. Opelz, 1989. Autoantibodies against CD4- and CD8-positive T lymphocytes in HIV-infected hemophilia patients. Vox Sang. 57: 172–176.
Daniel, V., R. Weimer, R. Zimmerman, A. Huth-Kuhne, et al., 1991. Improving CD4+ lymphocyte counts in HIV-infected hemophilia patients: a favourable prognostic indicator? Immuno. Lett. 30: 27–30.
Darby, S.C., R. Doll, B. Thakrar, C.R. Rizza & D.R. Cox, 1990. Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK. Stat. Med. 9: 681–689.
De Biasi, R., A. Rocino, E. Miraglia, L. Mstrulle & A.A. Quirino, 1991. The impact of very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized prospective, two-year comparison with an intermediate purity concentrate. Blood 78: 1919–1922.
Donohoe, R.M. & A.A. Falek, 1988. Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS. In: T.P. Bridge (ed.) Psychological, Neuropsychiatrie, and Substance Abuse Aspects of AIDS. New York: Raven Press, 165–172.
Downs, A.M., R.A. Ancelle-Park, D. Costagliola, J.P. Rigaut & J.B. Brunet, 1991. Transfusion-associated AIDS cases in Europe: Estimation of the incubation period, distribution and prediction of future cases. J. Acquir. Immune. Defic. Syndr. 4: 805–813.
Dudding, B.A., S.C. Wagner, J.A. Zeller, J.T. Gmelich, G.R. French & F.H. Top, Jr., 1972. Fatal pneumonia associated with adenovirus type 7 in three military trainees. New Engl. J. Med. 286: 1289–1292.
Duesberg, P.H., 1987. Retroviruses as carcinogens and pathogens. Expectations and reality. Cancer Res. 47: 1199–1226.
Duesberg, P.H., 1989. Human immunodeficiency virus and acquired immunodeficiency syndrome: Correlation but not causation. Proc. Natl. Acad. Sci. U.S.A. 86: 755–764.
Duesberg, P.H., 1990. AIDS: non-infectious deficiencies acquired by drug consumption and other risk factors. Res. Immunol. 141: 5–17.
Duesberg, P.H., 1992. The role of drugs in the origin of AIDS. Biomed. & Pharmacother. 46: 3–15.
Drew, W.L., J. Mills, J. Levy, etal.,1985. Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. Ann. Intern. Med. 103: 61–63.
European Study Group on AIDS, 1989. Risk factors for male to female transmission of HIV. Br. Med. J. 298: 411–415.
Eyster, M.E., M.H. Gail, J.O. Ballard, H. Al-Mondhiry & J.J. Goedert, 1987. Natural history of human immunodeficiency virus infections in hemophiliacs: effects on T-cell subsets, platelet counts and age. Ann. Intern. Med. 107: 1–6.
Farrugia, A., 1992. Purity of factor concentrates and immune function in hemophiliacs. Blood 78: 1919–1922.
Fauci, A.S., 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262: 1011–1018.
Farzadegan, H., M.A. Polis, S.M. Wolinsky, C.R. Rinaldo Jr., J.J. Sninsky, S. Kwok, R.L. Griffiths, R.A. Kaslow, J.P. Phair, B.F. Polk & A.A. Saah, 1988. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. Ann. Med. 108: 785–790.
Fernandez-Cruz, E., A.M. Fernandez, C. Gutierrez, et al., 1988. Progressive cellular immune impairment leading to development of AIDS: Two year prospective study of HIV infection in drug addicts. Clin. Exp. Immunol. 72: 190–195.
Fiala, M., L.A. Cone, C.-M. Chang & E.S. Mocarski, 1986. Cytomegalovirus viremia increases with progressive immune deficiency in patients infected with HTLV-III. AIDS Res. 2: 175–181.
Fribourg-Blanc, A., 1988. Deux observations d’annulation spontanee d’une sero-positivite HIV. Med. Mal. Infect. 4: 216–218.
Fumento, M., 1990. The Myth of Heterosexual AIDS, New York, Harpers.
Garry, R.F., J.J. Kort, F. Koch-Nolte & G. Koch, 1991. Tat contains a sequence related to snake neurotoxins. AIDS. 5: 1381–1384.
Gibbons, J., J.M. Cory, I.K. Hewlett, J.S. Epstein & M.E. Eyster, 1990. Silent infections with human immunodeficiency virus type 1 are highly unlikely in multitransfused seronegative hemophiliacs. Blood 76: 1924–1926.
Giesecke, J., G.P. Scalia-Tomba, O. Berglund, E. Berntorp, S. Schulman & L. Stigendal, 1988. Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. Br. Med. J. 297: 99–102.
Goedert, J.J., C.M. Kessler, L.M. Aledort, et al., 1989. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. New Engl. J. Med. 321: 1141–1148.
Golding. H., F.A. Robey, F.T. Gates III, W. Linder, et al., 1988. Indentification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. J. Exp. Med. 167,914–923.
Goldsmith, J.M., J. Deutsche, M. Tang & D. Green, 1991. CD4 cells in HIV-1 infected hemophiliacs: effect of Factor VIII concentrates. Thromb. Haemost. 66: 415–419.
Gottlieb, M.S., R.A. Zackin, M. Fiala, D.H. Henry, A.J. Marcel., K.L. Combs, J. Vieira, et al.,1991. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. Ann. Intern. Med. 115: 84–91.
Gomperts, E.D., R. De Biasi & R. De Vreker, 1992. The impact of clotting factor concentrates on the immune system in individuals with hemophilia. Transfus. Med. Rev. 6: 44–54.
Gougeon, M.-L. & L. Montagnier, 1993. Apoptosis and AIDS. Science 260: 1296–1271.
Groenbladh, L. & L. Gunne, 1989. Methadone-assisted rehabilitation of Swedish heroin addicts. Drug Alcohol Depend. 24:31–37.
Gürtler, L., J. Eberle & E Deinhardt, 1989. Seroreversion in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 110: 946–948.
Hadden, J.W., 1991. Immunotherapy of human immunodeficiency virus infection. Trends Pharmcol. Sci. 12: 107–111.
Halstead, S.B., 1988. Pathogenesis of dengue: Challenges to molecular biology. Science 29: 476–481.
Hamilton, J.R., J.C. Overall & L.A. Glasgow, 1976. Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aerugionsa, Staphylococcus aureus, or Candida albicans infections. Infect. Immunol. 14: 928–989.
Hardy, A.M., J.R. Allen, W.M. Morgan & J.W. Curran, 1985. The incidence rate of acquired immune deficiency syndrome in selected populations. JAMA 253: 215–218.
Hassett, J., G.F. Gjerset, J.W. Mosley, M.A. Fletcher, et al., 1993. Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-l-negative congenital clotting disorders. Blood 82: 1351–1357.
Haverkos, H.W., 1988. Kaposi’s sarcoma and nitrite inhalants. In: T.P. Bridge (ed.) Psychological, Neuropsychiatrie, and Substance Abuse Aspects of AIDS. New York: Raven Press, 165–172.
Hay, C.R., P. McEvoy & M. Duggan-Keen, 1990. Inhibitions of lymphocyte IL2-receptor expression by factor VIII concentrate: a possible cause of immune suppression in haemophiliacs. Br. J. Haematol. 75: 278–281.
Hendricks, I.C., G.F. Medley, G.J. Van Griensven, R.A. Coutinho, et al., 1993. The treatment-free incubation period of AIDS in a cohort of homosexual men. AIDS 7: 231–239.
Henrard, D.R.Y. Laurian, W.F. Mehaffey & J.P Allain, 1993. Lack of detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction in the plasma and lymphocytes of seronegative exposed hemophiliacs. Transfusion 33: 405–408.
Higgins, J.A. & A.H. Goodall, 1991. Immune activation in HIVseronegative hemophiliacs: Is this related to infection with hepatitis C virus? Thromb. Haemost. 65: 1163 (abstr. 1682).
Hilgartner, M.W., J.D. Buckley, E.A. Operskalsi, M.C. Pike & J.W. Mosely, 1993. Purity of factor VIII concentrates and serial CD4 counts. Lancet 341: 1373–1374.
Hoff, C. & R.D.A. Peterson, 1989. Does exposure to HLA alloantigens trigger immunoregulatory mechanisms operative in both pregnancy and AIDS? Life Sci. 45: iii-ix.
Hoff, C., W.C. James, R.B. Hester, P. Nolan & R.D.A. Peterson, 1991. Signs of cellular immunosuppression correlate with HLADR phenotypes in healthy HIV-negative homosexuals: preliminary findings. Human Biology 63: 129–135.
Holman, R.C., P.H. Rodes, T.L. Chorba & B.L. Evatt, 1992. Survival of hemophiliac males with acquired immunodeficiency syndrome with and without risk factors for AIDS other than hemophilia. Am. J. Hematol. 39: 275–282.
Hoover, D.R., A.J. Saah, H. Bacellar, et al., 1993. Clinical manifestation of AIDS in the era of pneumocystis prophylaxis. New Engl. J. Med. 329: 1922–1926.
Horsburgh, C.R., Jr., C.Y. Ou, J. Jason, et al., 1990. Concordance of polymerase chain reaction with human immunodeficiency virus antibody detection. J. Infect. Dis. 162: 542–545.
Huang, S.-W. & R. Hong, 1973. Lymphopenia and multiple viral infections. JAMA 225: 1120–1121.
Huang, S.-W., D.B. Lattos, D.B. Nelson, K. Reb & R. Hong, 1973. Antibody-associated lymphotoxin in acute infection. J. Clin. Invest. 52: 1033–1040.
Hughes, M.D., D.S. Stein, H.M. Gundacker, F.T. Valentine, J.P. Phair & P.A. Volberding, 1994. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: Implications for patient monitoring. J. Infect Dis. 169: 28–36.
Imagawa, D. & R. Detels, 1991. HIV-1 in seronegative homosexual men. NEJM 325: 1250–1251.
Jaffe, H.W., P.M. Feorino, W.W. Darrow, et al., 1985. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men. Ann. Intern. Med. 102: 627.
Judson, F.N., 1990. The relationship of HIV infections to infections with pathogenic Neisseria in homosexual men. Med. Clin. North. Am. 74: 1353–1366.
Kallenius, G., S.E. Hoffner & S.B. Svenson, 1989. Does vaccination with bacille Calmette-Guerin protect against AIDS? Rev. Infect. Dis. 11: 349–351.
Keay, S., C.O. Tacket, J.R. Murphy & B.S. Handwerger, 1992. Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 or HIV-1 or infected with HIV-1. AIDS Res. Human Retroviruses 8: 1091–1098.
Kion, T.A. & G.W. Hoffmann, 1991. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science 253: 1138–1140.
Klenk, H.D. & R. Rott, 1988. The molecular biology of influenza virus pathogenicity. Adv. Virus Res. 34: 247–281.
Kliks, S.C., A. Nisalak, W.E. Brandt, et al., 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40: 444–451.
Knüver-Hopf, J., H. Heinze, B. Lambrecht, H. Mohr, J. Beyer & H. Schmitt, 1993. Blood donations indeterminate in HIV-1 Western blot analysed by 1gM immunoblot and polymerase chain reaction. Vox Sang. 64: 89–93.
Kopec-Schrader, E., B. Tindall, J. Learmont, B. Wylie & J.M. Kaldor, 1993. Development of AIDS in people with transfusion-acquired HIV infection. AIDS 7: 1009–1013.
Krasinski, K., W. Borkowsky & R.S. Holzman, 1989. Prognosis of human immunodeficiency virus infection in children and adolescents. Pediatr. Infect. Dis. J. 8: 216–220.
Lafeuillade, A. & R. Quilichine, 1992. HIV cofactors in the course of AIDS. Presse Med. 21: 1426–1430.
Lang, Ph., P. Niaudet, and the Groupe Cooperatif de Transplantation de l’Ile de France, 1991. Update and outcome of renal transplant patients with human immunodeficiency virus. Transplantation Proc. 23: 1352–1353.
Laurence, J., 1993. T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia. Ann. Intern. Med. 119: 55–62.
Levy, J., 1988. The transmission of AIDS: the case of the infected cell. JAMA 259: 3037–3038.
Littlefield, J.W., 1992. Possible supplemental mechanisms in the pathogenesis of AIDS. Clin. Immunol. Immunopathol. 65: 85–97.
Lo, S.-H., S. Tsai, J.R. Benish, et al., 1991. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma. Science 251: 1074–1076.
Lorenzo, J.I., R. Molina & J.A. Aznar, 1993. Evolution of CD4 and CD8 lymphocyte subsets in HIV seronegative and seropositive hemophiliacs. Sangre Barc. 38: 5–11.
Ludlum, C.A., J. Tucker, C.M. Steel, et al., 1985. Human Tlymphotropic virus type III (HTLV-III) infection in seronegative hemophiliacs after transfusions of factor VIII. Lancet 11: 233–236.
Lui, K.-J., D.N. Lawrence, W.M. Morgan, T.A. Peterman, H.W. Haverkos & D.J. Bregman, 1986. A model based approach for estimating the mean incubation period of transfusion-associated acquired immunodeficiency syndrome. Proc. Natl. Acad. Sci. U.S.A. 83: 301–305.
Lusso, P., R. Ensoli, P.D. Markham, et al., 1989. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature (Lond.), 337: 370–373.
Lusso, E, F. Lori & R.C. Gallo, 1990. CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses. J. Virol. 64: 6341–6344.
Macon, W.R., S.-C. Lo, B.J. Poisz, D.C. Monefiori, et al., 1993. Acquired immunodeficiency-syndrome-like illness associated with systemic Mycoplasma fermentans infection in a human immunodeficiency virus-negative homosexual man. Human Pathol 24:
Madhok, R., J.A. Gracie, J. Smith, G.D. Lowe & C.D. Forbes, 1990. Capacity to produce interleukin 2 is impaired in haemophilia in the absence and presence of HIV 1 infection. Br. J. Haematol. 76: 70–74.
Madhok, R., J. Smith, A. Jenkins & G.D.O. Lowe, 1991. T-cell sensitization to factor VIII in haemophilia A? Br. J. Haematol. 79: 235–238.
Mannucci, P.M., A. Gringeri, R. De Biasi, F. Baudo, M. Morfini & N. Ciavarella, 1992. Immune status of asymptomatic HIV-infected haemophiliacs: randomized, prospective, two-year comparison of treatment with high-purity or an intermediate-purity factor VIII (FVIII). Thromb. Haemost. 67: 310–313.
Mares, M., M.T. Sartori & A. Girolami, 1992. Prevalence of bleeding as cause of death in HIV-seropositive patients with congenital clotting disorders. Vox Sang. 63: 77–78.
Mathé, G., 1992. Is the AIDS virus responsible for the disease? Biomed. Pharmacother. 46: 1–2.
McClean, A.R. & M.A. Nowak, 1992. Models of interactions between HIV and other pathogens. J. Theor. Biol. 155: 69–86.
McDougal, J.S., M. Hubbard, J.K.A. Nicholson, et al., 1985. Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect. J. Clin. Immunol. 5: 130.
Medawar, P.B., 1967. The art of the soluble. London: Methuen.
Medley, G.F., R.M. Anderson, D.R. Cox & L. Billard, 1987. Incubation period of AIDS in patients infected via blood transfusion. Nature 328: 719–721.
Mills, L.B., 1986. Stimulation of T-cellular immunity by cutaneous application of dinitrochlorobenzene. J. Am. Acad. Dermatol. 14: 1089–1090.
Minkoff, H., D. Nanda, R. Menez & S. Fikrig, 1987. Pregnancies resulting in infants with acquired immunodeficiency syndrome or AIDS-related complex: follow-up of mothers, children, and subsequently born siblings. Obstet. Gynecol. 69: 288–291.
Montagnier, L., D. Bernman, D. Guetard, A. Blanchard, et al., 1990. Inhibition de l’infectiosite de souches prototype du VIH par des anticorps diriges contre une sequence peptideque de mycoplasme. Comptes rendus Acad. Sci. Paris 311: 425–430.
Montaner, J.S., L.M. Lawson, A. Gervais, et al.,1991. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo-controlled study. Ann. Intern. Med. 114: 948–953.
Moretti, M.L., 1992. Specific behavioural factors among intravenous drug users have been shown to influence HIV seroconversion… J. InterAm. Med. Health. Assoc. 1: 1–8.
Morrow, W.J.W., D.A. Isenberg, R.E. Sobol, R.B. Stricker & T. Keiber-Emmons, 1991. AIDS virus infection and autoimmunity: A perspective on the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease. Clin. Immunol. Immunopathol. 58,163–180.
Msellati, E, M. Dupon, P. Morlat, D. Lacoste, et al., 1990. A cohort study of 89 HIV-1-infected adult patients contaminated by blood products: Bordeaux 1981–1989. AIDS 4: 1105–1109.
Munoz, A., V. Carey, A.J. Saah, et al., 1988. Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J. Acquir. Immune. Defic. Syn. 1: 396.
National Research Council. 1990. AIDS: The Second Decade National Academy of Sciences, Washington, D.C.
Naz, R.K., M. Ellauri, T.M. Phillips & J. Hall, 1990. Antisperm antibodies in human immunodeficiency virus infection: Effects on fertilization and embryonic development. Biol. Reprod. 42: 859–868.
Odell, T.W. & J.A. Green, 1990. Prolonged zidovudine therapy: confounded by Pneumocysitis carinii prophylaxis? JAMA 263: 1635.
Oehen, S., H. Hengartner & R.M. Zinkernagel, 1991. Vaccination for disease. Science 251: 195–198.
Ozturk, G.E., P.F. Kohler, C.R. Horsburgh & C.H. Kirkpatrick, 1987. The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners. J. Clin. Immunol. 7: 130–133.
Padian, N.S., S.C. Shiboski & N.P. Jewell, 1990. The effect of number of exposures on the risk of heterosexual HIV transmission. J. Infect. Dis. 161: 883–887.
Palestine, A.G., M.A. Polis, M.D. De Smet, et al., 1991. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann. Intern. Med. 115:665–671.
Papadopulos-Eleopulos, E., 1988. Reappraisal of AIDS. Is the oxidation induced by the risk factors the primary cause? Med. Hypotheses 25: 151–162.
Perrin, L.H., R. Zubler, B. Hirschel, J.L. Martin, D. Salomon, J.H. Sauret & O. Fryc, 1988. Negativation d’une serologie positive pour le virus d’immunodefience humaine (VIII). A propos de deux observations. Schweiz. Med. Wochenschrt. 118/45: 1641–1644.
Peterman, T.A., R.L. Stoneburner, J.R. Allen, H.W. Jaffe & J.W. Curran, 1988. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA 259: 55–58.
Pifer, L.W., Y.F. Wang, T.M. Chiang, R. Ahokas, D.R. Woods & R.E. Joyner, 1987. Borderline immunodeficiency in male homosexuals: Is lifestyle contributory? South. Med. J. 80: 687–697.
Popper, K., 1962. Conjectures and refutations. The growth of scientific knowledge. New York: Basic Books.
Porterfield, J.S., 1986. Antibody-dependent enhancement of viral activity. Adv. Virus. Res. 31: 335–353.
Rahman, M.A., L.A. Kingsley, M.K. Berinig, et al., 1989. Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus. J. Clin. Microbiol. 29: 1215–1220.
Ribot, S. & H.H. Eslami, 1992. HIV infection in kidney transplant recipients. N. J. Med. 89: 597–599.
Rinaldo, C.R. Jr., L.A. Kingsley, D.W. Lyter, et al., 1986. Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men. J. Infect. Dis. 154: 556–561.
Rinaldo, C.R., Jr., L.A. Kingsley, M. Ho, J.A. Armstrong & S.Y.J. Zhou, 1992. Enhanced shedding of cytomegalovirus in semen of human immunodeficiency virus-seropositive homosexual men. J. Clin. Microbiol. 30: 1148–1155.
Ritter, M., 1994. AIDS raises death rate for hemophilia. Associated Press release based on CDC press conference, 3 Feb. 1994.
Roithmann, S., J.M. Tourani, J.A. Gastaut, P. Brice, et al., 1993. Hodgkin’s disease associated with HIV infection: clinical characteristics and development. Bull. Cancer. Paris. 79: 873–882.
Root-Bernstein, R.S., 1989. Discovering, Inventing and solving problems at the frontiers of knowledge. Cambridge, MA: Harvard University Press.
Root-Bernstein, R.S., 1990a. Do we know the cause(s) of AIDS? Persp. Biol. Med. 33: 480–500.
Root-Bernstein, R.S., 1990b. Multiple-antigen-mediated autoimmunity (MAMA) in AIDS: a possible model for postinfectious autoimmune complications. Res. Immunol. 141: 321–339.
Root-Bernstein, R.S., 1990c. Non-HIV immunosuppressive agents in AIDS: a multifactorial, synergistic theory of AIDS aetiology. Res. Immunol. 141: 815–838.
Root-Bernstein, R.S., 1991. Self, nonself, and the paradoxes of autoimmunity. In: A.I. Tauber, ed. Organism and the Development of Self. Kluwer Academic, pp. 159–209.
Root-Bernstein, R.S., 1992a. HIV and immunosuppressive cofactors in AIDS. EOS. Rev. Immunol. lmmunopharm. 12: 256–262.
Root-Bernstein, R.S., 1992b. AIDS is more than HIV. Genetic Engineering News 12 no. 13: 4–6; 12 no. 14:4–5.
Root-Bernstein, R.S., 1993. Rethinking AIDS. The Tragic Cost of Premature Concensus. New York: Free Press.
Root-Bernstein, R.S., 1994. Preliminary evidence of idiotypeantiidiotype immune complexes cross-reactive with lymphocyte antigens resulting from pairs of infectious agents associated with AIDS and lupus. Med. Hypoth. In press.
Root-Bernstein, R.S. & S.H. Hobbs. 1991. Homologies between mycoplasma adhesion pepetide, CD4, and class II MHC proteins: a possible mechanism for HIV-mycoplasma synergism in AIDS. Res. Immunol. 142: 519–523.
Root-Bernstein, R.S. & S.H. Hobbs, 1993. Does HIV `piggyback’ on CD4-like surface proteins of sperm, viruses, and bacteria? Implications for co-transmission, cellular tropism and the induction of autoimmunity in AIDS. J. Theor. Biol. 160: 249–264.
Root-Bernstein, R.S. & S.H. DeWitt, 1994. CD4 similarity to proteins of infectious agents in AIDS, and autoimmunity. Med. Hypoth. In press.
Rosendaal, F.C., C. Smit & E. Briet, 1991. Hemophilia treatment in historical perspective: a review of medical and social developments. Ann. Hematol. 62: 5–25.
Roy, M.J., J.J. Damato & D.S. Burke, 1993. Absence of true seroreversion of HIV-1 antibody in seroreactive individuals. JAMA 269: 2876–2879.
Rubenstein, A., M. Sicklick, A. Gupta, L. Bernstein, N. Klein, et al.,1983. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA 249: 2350–2356.
Rubin, H., 1988. Etiology of AIDS. Science 214: 1389–1390.
Sabin. A., 1988. Effectiveness of AIDS vaccines. Science 251: 1161.
Sabin, C., A. Phillips, J. Elford, P. Griffiths, G. Janossay & C. Lee, 1993. Progression of HIV disease in a haemophiliac cohort followed for 12 years. Br. J. Haemoatol. 83: 330–335.
Salk, J.P.A. Bretscher, P.L. Salk, M. Clerici & G.M. Shearer, 1993. A strategy for prophylactic vaccination against HIV. Science 260: 1270–1272.
Schinaia, N., A. Ghirardini, F. Chiarotti, A. Gringeri, P.M. Mannucci, et al., 1991. Progression of AIDS among Italian HIVseropositive haemophiliacs. AIDS 5/4: 385–391.
Schulman, S., 1991. Effects of factor VIII concentrates on the immune system of hemophiliac patients. Ann. Hematol. 63; 145–151.
Schwarz, A., G. Offerman, F. Keller, I. Bennhold, J. L’age-Stehr, P.H. Krause & M.J. Mihatsch, 1993. The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation data on four cases and review of the literature. Transplantation 55: 95–103.
Shearer, G.M. & R.B. Levy, 1984. Noninfectious cofactors in susceptibility to AIDS: possible contributions of semen, HLA alloantigens, and lack of natural resistance. Ann. N. Y. Acad. Sci. 437: 49–57.
Shope, E., 1931. Swine influenza, III. Filtration experiments and etiology. J. Exp. Med. 54: 373–385.
Sonnabend, J.A., 1989. AIDS: An explanation for its occurrence in homosexual men. In: AIDS and Opportunistic Infections of Homosexual Men, P. Ma and D. Armstrong, eds. Butterworth Publishers, Stoneham, MA, pp. 450–460.
Sonnabend, J.A. & S. Saadoun, 1984. The acquired immunodeficiency syndrome: A discussion of etiologic hypothesis. AIDS Res. 1: 107–120.
Sonnabend, J.A., S.S. Witkin & D.T. Portillo, 1984. A multifactorial model for the development of AIDS in homosexual men. Ann. N. Y. Acad. Sciences 437: 177–182.
Sorice, F., A. Ghirardini, P. Martino, D. Pasqualetti, et al., 1989. Spectrum of HIV infection and AIDS in a cohort of Italian hemophiliacs. Haemotologica 74: 149–154.
Stehr-Green, J.K., J.M. Jason, B.L. Evatt, R.C. Holman, et al., 1989. Geographic variability of hemophilia-associated AIDS in the United States: Effect of population characteristics. Am. J. Hematol. 32: 178–183.
Stott, E.J., 1991. Anti-cell antibody in macaques. Nature 353: 393–395.
Stricker, R.B., T.M. McHugh, D.J. Moody, W.J.M. Morrow, D.P. Stites, M.A. Shuman & J.A. Levy, 1987a. An AIDS-related cytotoxic antoantibody reacts with a specific antigen on stimulated CD4+ cells. Nature 327: 710–713.
Stricker, R.B., T.M. McHugh, P.A. Marx, W.J.M. Morrow, J.A. Levy, M.A. Shuman, D.P. Stites & P.D. Nyeman, 1987b. Prevalence of an AIDS-related autoantibody against CD4+ T-cells in humans and monkeys. Blood 70: 127A.
Stricker, R.B., B.F. Elswood & D.I. Abrams, 1991. Dendritic cells and dinitrochlorobenzene (DNCB): a new treatment approach to AIDS. Immunol. Lett. 29: 191–196.
Stricker, R.B., B.F. Elswood, D.I. Abrams, et al., 1993. Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection. Immunol. Lett. 36: 1–6.
Sullivan, J.L., F.E. Brewster, D.B. Brettler, et al., 1986. Hemophiliac immunodeficiency: Influence of exposure to factor VIII concentrate, LAV-HTLV-III, and herpes viruses. J. Pediatr. 108: 504–510.
Sumaya, C.V., R.N. Boswell, Y. Ench, et al.,1985. Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS related complex. J. Infect Dis. 154: 864.
Süsal, C., M. Kröpelin, V. Daniel & G. Opelz, 1993. Molecular mimicry between HIV-1 and antigen receptor molecules: a clue to the pathogenesis of AIDS. Vox Sang. 65: 10–17.
Tanenbaum, S.A., R.F. Garry, H. Luo-Zhang, S.S. Alexander & C.A. Leissinger, 1993. Humoral and cellular responses against HIV in multitransfused HIV seronegative hemophiliacs. Absts. 1st National Conf. Human Retroviruses. Abst. #86, p. 71.
Tanenbaum, S.A., C.A. Leissinger & R.P. Garry. 1993. Absence of seroconversion of HIV-1 antibody in seroreactive individuals. JAMA 270: 2178.
Taylor, J.M., J.M. Duo & R. Detels, 1991. Is the incubation period of AIDS lengthening? J. Acquir. Immune. Defic. Syndr. 4: 69–75.
Tzakis, A.G., M.H. Cooper, J.S. Dummer, M. Ragni, J.W. Ward & T.E. Starzl, 1990. Transplantation in HIV+ patients. Transplantation 49: 354–358.
Urnovitz, H.B., M. Clerici, G.M. Shearer, T.D. Gottfried, D.J. Robinson, L.I. Lutwick, L. Montagnier & D.V. Landers, 1993. HIV-1 antibody serum negativity with urine positivity. Lancet 342: 1458–1459.
Vamvakas, E. & H.S. Kaplan, 1993. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion 33: 111–118.
Vandenbroucke, J.P. & V.P.A.M. Pardoel, 1989. An autopsy on epidemiologic methods: the case of `poppers’ in the early epidemic of the acquired immunodeficiency syndrome (AIDS). Am. J. Epidem. 129: 455–457.
Van Griensven, G.J., E.M. de Vroom, J. Goodsmit & R.A. Coutinho, 1989. Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. Br. Med. J. 298: 218–221.
Vega, M.A., R. Guigo & T.F. Smith, 1990. Autoimmune response in AIDS. Nature 345: 26.
Wang, M.C. & L.C. See, 1992. N-estimation from retrospectively ascertained events with application to AIDS. Biometrics 48: 129–141.
Wang, R.Y., J.W. Shih, T. Grandinetti, P.F. Pierce, M.M. Hayes, D.J. Wear, H.J. Alter & S.C. Lo, 1992. High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients. Lancet 340: 1312–1316.
Ward, J.W., T.J. Bush, H.A. Perkins, et al., 1989. The natural history of transfusion-associated infection with human immunodeficiency virus. New Engl. J. Med. 321: 947–952.
Watson, H.G. & C.A. Ludlum, 1992. Immunological abnormalities in haemophiliacs. Blood Rev. 6: 26–33.
Weber, R., W. Ledergerber, M. Opravil, W. Siegenthaler & R. Lüthy, 1990. Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. Br. Med. J. 301: 1361–1365.
Webster, A., C.A. Lee, D.G. Cook, J.E. Grundy, et al., 1989. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet 11: 63–66.
Weiss, R.A., 1993. How does HIV cause AIDS? Science 260: 1273–1279.
Weyer, J. & H.J. Eggers, 1990. On the structure of the epidemic spread of AIDS: the influence of an infectious coagent. Int. J. Med. Microbiol. 273: 52–67.
Winkelstein, W. Jr., J.A. Wiley, N.S. Padian, M. Samuel, S. Shiboski, M.S. Ascher & J.A. Levy, 1988. The San Francisco Men’s Health Study: Continued decline in HIV seroconversion rates among homosexual/bisexual men. Am. J. Public Health 78: 1472–1474.
Witebsky, E., N.R. Rose, K. Terplan, J.R. Pain & R.W. Egan, 1957. Chronic thyroiditis and autoimmunization. JAMA 164: 1439–1447.
Zarling, J.M., J.A. Ledbetter, J. Sias, P. Fultz, J. Eichberg, G. Gjerset & P.A. Moran, 1990. HIV-infected humans but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells. J. Immunol. 144, 2992–2998.
Ziegler, J.L. & D.P. Stites, 1986. Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropicretrovirus. Clin. Immunol. Immunopathol. 41: 305.
Zuck, T.F., 1988. Silent sequences and the safety of blood transfusions. Ann. Intern. Med. 108: 895–896.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Root-Bernstein, R.S. (1996). Five myths about AIDS that have misdirected research and treatment. In: Duesberg, P.H. (eds) AIDS: Virus- or Drug Induced?. Contemporary Issues in Genetics and Evolution, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1651-7_15
Download citation
DOI: https://doi.org/10.1007/978-94-009-1651-7_15
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-3961-8
Online ISBN: 978-94-009-1651-7
eBook Packages: Springer Book Archive